Cancer in Scotland: Action for Change set a target that "the maximum wait from urgent referral to treatment for all cancers will be two months"
Upper GI - period of diagnosis: 1 January to 31 March 2007
Area of diagnosis | Number of eligible urgent referrals* | Number treated within 2 months (62 days) of referral | % compliance with 2 month urgent referral to treatment target | Minimum wait (Days) | Maximum wait (Days) | Median wait (Days) | 90th Percentile (Days) |
| | | | | | | |
Scotland | 247 | 209 | 84.6% | 1 | 138 | 29 | 77 |
| | | | | | | |
NOSCAN | 73 | 61 | 83.6% | 3 | 104 | 29 | 77 |
Argyll & Clyde (Highland) | - | - | n/a | n/a | n/a | n/a | n/a |
Grampian | 28 | 25 | 89.3% | 4 | 76 | 32 | 72 |
Highland | 12 | 7 | 58.3% | 5 | 104 | 42 | 101 |
Orkney | 1 | 1 | 100.0% | 32 | 32 | n/a | n/a |
Shetland | - | - | n/a | n/a | n/a | n/a | n/a |
Tayside | 31 | 27 | 87.1% | 3 | 95 | 24 | 81 |
Western Isles | 1 | 1 | 100.0% | 30 | 30 | n/a | n/a |
| | | | | | | |
SCAN | 59 | 52 | 88.1% | 1 | 101 | 22 | 80 |
Borders | 3 | 3 | 100.0% | 13 | 46 | 14 | n/a |
Dumfries & Galloway | 6 | 5 | 83.3% | 1 | 96 | 24 | n/a |
Fife | 22 | 18 | 81.8% | 7 | 99 | 35 | 88 |
Lothian | 28 | 26 | 92.9% | 2 | 101 | 14 | 56 |
| | | | | | | |
WOSCAN | 115 | 96 | 83.5% | 1 | 138 | 29 | 78 |
Argyll & Clyde (Greater Glasgow) | 17 | 12 | 70.6% | 6 | 131 | 40 | 125 |
Ayrshire & Arran | 18 | 15 | 83.3% | 1 | 138 | 23 | 85 |
Forth Valley | 10 | 8 | 80.0% | 9 | 88 | 44 | 86 |
Lanarkshire | 23 | 17 | 73.9% | 1 | 113 | 31 | 94 |
Greater Glasgow | 47 | 44 | 93.6% | 1 | 124 | 23 | 59 |
*Exclusion categories are: died prior to receiving treatment, refused treatment, patient induced non-clinical delay, co-morbidities, clinical reasons and initially referred to another non-cancer specialty.
n/a: Not applicable due to small numbers
Cancer waiting times statistics are subject to a programme of quality improvement focusing on consistency and coverage.
These improvements need to be taken in to account when making comparisons on quarter on quarter performance.